Registration gives the benefit of receiving regular site update emails.
ADHD Institute Register

13 Jan 2016

Fredriksen M, Peleikis DE.Basic Clin Pharmacol Toxicol 2016; 118: 23-31.

Long-term pharmacotherapy in adults may be efficacious and well tolerated, a recent literature review and clinical study has reported.

Researchers investigated the effect of prolonged drug treatment on long-term outcomes in adults with ADHD. Although a systematic literature review revealed few long-term (≥24 weeks) treatment studies in adults with ADHD, ADHD medication was found to be more efficacious versus placebo in all included randomised controlled trials (n=4). Furthermore, efficacy was maintained or improved during the follow-up period in short-term studies with extension phases of up to 1 year (n=9). Researchers judged medication to be well tolerated by most patients.

A prospective clinical study in medication-naïve outpatient adults with ADHD (n=250) was conducted to investigate the effectiveness of medication administered in accordance with current clinical guidelines (combined with usual psychosocial interventions) over a 1-year period. A follow-up evaluation at 12 months was completed by 93% of patients, of whom 70% remained on medication. Significant improvements in symptoms* and functioning were observed in adults still medicated at 12 months, compared with those who were not (both p<0.001). Of 69 (28%) patients who had discontinued treatment before the 12 month follow-up, 31 (12%) terminated due to adverse events; no serious adverse events occurred.

Researchers concluded that these results were indicative of favourable effects associated with ADHD medication maintained over a prolonged period. More longitudinal studies would be useful in helping clinicians make informed decisions about long-term pharmacotherapy in adults with ADHD.

Read more about benefits of long-term pharmacotherapy in adults here


*Adult ADHD Self-Report Scale version 1.1
Global Assessment of Functioning (investigator-rated)

Fredriksen M, Peleikis DE. Long-term pharmacotherapy of adults with attention deficit hyperactivity disorder: a literature review and clinical study. Basic Clin Pharmacol Toxicol 2016; 118: 23-31.

Filter content by:

ADHD Institue logo

You’re now being transferred to

and are leaving the ADHD Institute site

Shire has no influence or control over the content of this third party website.

Continue Cancel